Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs

Cell-based immunotherapies have been selected for the front-line cancer treatment approaches. Among them, CAR-T cells have shown extraordinary effects in hematologic diseases including chemotherapy-resistant acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghanloo, Ehsan, Mollanoori, Hasan, Talebi, Mohsen, Pashangzadeh, Salar, Faraji, Fatemeh, Hadjilooei, Farimah, Mahmoodzadeh, Habibollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027274/
https://www.ncbi.nlm.nih.gov/pubmed/33789222
http://dx.doi.org/10.1016/j.tranon.2021.101070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027274/
https://www.ncbi.nlm.nih.gov/pubmed/33789222
http://dx.doi.org/10.1016/j.tranon.2021.101070

Ejemplares similares